Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in: Current Psychiatry Reports 3/2010

01-06-2010

Catatonia: Diagnosis, Classification, and Treatment

Author: Andrew Francis

Published in: Current Psychiatry Reports | Issue 3/2010

Login to get access

Abstract

Catatonia is a distinct neuropsychiatric syndrome that is becoming more recognized clinically and in ongoing research. It occurs with psychiatric, metabolic, or neurologic conditions. It may occur in many forms, including neuroleptic malignant syndrome. Treatment with benzodiazepines or electroconvulsive therapy leads to a dramatic and rapid response, although systematic, randomized trials are lacking. An important unresolved question is the role of antipsychotic agents in treatment and their potential adverse effects.
Literature
1.
Kahlbaum KL: Catatonia. Translated by Levi Y, Pridon T. Baltimore, MD: Johns Hopkins University Press; 1973.
2.
Rosebush PL, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51:357–362.PubMed
3.
Francis A: Update on catatonia. Psychiatr Times 2006, 23:23–24.
4.
Benegal V, Hingorani S, Khanna S: Idiopathic catatonia: validity of the concept. Psychopathology 1993, 26:41–46.CrossRefPubMed
5.
Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003, 160:1233–1241.CrossRefPubMed
6.
Koch M, Chandragiri S, Rizvi S, et al.: Catatonic signs in neuroleptic malignant syndrome. Compr Psychiatry 2000, 41:73–75.CrossRefPubMed
7.
Francis A, Chandragiri S, Rizvi S, et al.: Is lorazepam a treatment for neuroleptic malignant syndrome? CNS Spectr 2000, 5:54–57.PubMed
8.
Khaldarov V: Benzodiazepines as a treatment for neuroleptic malignant syndrome. Hosp Physician 2000, 6:51–55.
9.
Petrides G, Malur C, Fink M: Convulsive therapy. In Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC: American Psychiatric Press; 2004:151–160.
10.
11.
Yacoub A, Francis A: Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Neuropsychiatr Dis Treat 2006, 2:235–240.CrossRefPubMed
12.
Bush G, Petrides G, Francis A: Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res 1997, 27:83–92.CrossRefPubMed
13.
Starkstein SE, Petracca G, Teson A, et al.: Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 1996, 60:326–332.CrossRefPubMed
14.
Bush G, Fink M, Petrides G, et al.: Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996, 93:129–136.CrossRefPubMed
15.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
16.
Bush G, Fink M, Petrides G, et al.: Catatonia II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996, 93:137–143.CrossRefPubMed
17.
Lee JWY, Schwartz DI, Hallmayer J: Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000, 12:89–96.PubMed
18.
Northoff G, Koch A, Wenke A, et al.: Catatonia as a psychmotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord 1999, 14:404–416.CrossRefPubMed
19.
Bräunig P, Kruger S, Shugar G, et al.: The catatonia rating scale—development, reliability, and use. Compr Psychiatry 2000, 41:147–158.CrossRefPubMed
20.
Cohen D: Towards a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol 2006, 72:131–147.CrossRefPubMed
21.
Cohen D, Flament M, Dubos PF, Basquin M: Case series: catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 1999, 38:1040–1046.PubMedCrossRef
22.
Dhossche D, Wing, L, Ohta M, Jurge-Neumarker K: Catatonia in Autism Spectrum Disorders. San Diego, CA: Academic Press; 2006.
23.
Kakooza-Mwesige A, Wachtel LE, Dhossche DM: Catatonia in autism: implications across the life span. Eur Child Adolesc Psychiatry 2008, 17:327–335.CrossRefPubMed
24.
Esmaili T, Malek A: Electroconvulsive therapy (ECT) in a six-year-old girl suffering from major depressive disorder with catatonic features. Eur Child Adolesc Psychiatry 2007, 16:58–60.CrossRefPubMed
25.
26.
Carroll BT, Kennedy JC, Goforth HW: Catatonic signs in medical and psychiatric catatonias. CNS Spectr 2000, 5:66–69.PubMed
27.
Cottencin O, Warembourg F, de Chouly de Lenclave M, et al.: Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1170–1176.
28.
Francis A, Lopez-Canino A: Delirium with catatonic features—a new subtype? Psychiatr Times 2009, 26:15–18.
29.
Taylor MA: Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1990, 3:48–72.
30.
Barnes MP, Saunders M, Walls TJ, et al.: The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 1986, 49:991–996.CrossRefPubMed
31.
Stöber G: Genetics. In Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC: American Psychiatric Press; 2004:173–188.
32.
Northoff G: Neuroimaging and neurophysiology. In Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC: American Psychiatric Press; 2004:77–92.
33.
Carroll BT: The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr 2000, 5:26–33.PubMed
34.
McCall WV, Shelp FE, McDonald WM: Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992, 149:202–206. (Published erratum appears in Am J Psychiatry 1992, 149:720.)
35.
Rosebush P, Mazurek M. Pharmacotherapy. In Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC: American Psychiatric Press; 2004:141–150.
36.
Wetzel H, Heuser I, Benkert O: Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 1987, 175:240–242.CrossRefPubMed
37.
Ungvari GS, Chiu HF, Chow LY, et al.: Lorazepam for chronic catatonia: a randomized double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl) 1999, 142:393–398.CrossRef
38.
•• Thomas P, Cottencin O, Rascle C, et al.: Catatonia in French psychiatry: implications of the zolpidem challenge test. Psychiatr Ann 2007, 37:45–54. This was an update on an important new treatment for catatonia, zolpidem.
39.
Carroll, BT, Goforth HW, Thomas C, et al.: Review of adjunctive glutamate antagonist therapy in the treatment of catatonia syndromes. J Neuropsychiatry Clin Neurosci 2007, 19:406–412.
40.
Petrides G, Divadeenam K, Bush G, Francis A: Synergism of lorazepam and ECT in the treatment of catatonia. Biol Psychiatry 1997, 42:375–381.CrossRefPubMed
41.
Hawkins JM, Archer KJ, Strakowski SM, Keck PE: Somatic treatment of catatonia. Int J Psychiatry Med 1995, 25:354–369.
42.
White DA, Robins AH: An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS Spectr 2000, 5:58–65.PubMed
43.
Van Den Eede F, Van Hecke J, Van Dalfsen A, et al.: The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005, 20:422–429.CrossRef
44.
Martenyi F, Metcalfe S, Schausberer B, Dossenbach MR: An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. J Clin Psychiatry 2001, 62(Suppl 2):25–27.PubMed
45.
Girish K, Gill NS: Electro convulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry 2003, 45:21–25.
46.
Mann SC, Caroff SN, Fricchione GL, et al.: Malignant catatonia. In Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC: American Psychiatric Press; 2004:105–120.
Metadata
Title
Catatonia: Diagnosis, Classification, and Treatment
Author
Andrew Francis
Publication date
01-06-2010
Publisher
Current Science Inc.
Published in
Current Psychiatry Reports / Issue 3/2010
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-010-0113-y

Other articles of this Issue 3/2010

Current Psychiatry Reports 3/2010 Go to the issue

ReviewPaper

Psychosomatic Medicine is a Comprehensive Field, Not a Synonym for Consultation Liaison Psychiatry

ReviewPaper

The Impact of Depression in Heart Disease

ReviewPaper

Anticoagulation and Psychotropic Medications

ReviewPaper

Psychiatric Aspects of Chronic Fatigue Syndrome and Fibromyalgia

ReviewPaper

The Pathology of Paraphrenia

ReviewPaper

Excess Suicide Risk and Other External Causes of Death Among Women with Cosmetic Breast Implants: A Neglected Research Priority